Medical Cannabis Advocacy in the Middle East During the 1970s
A brief look at what actually happened with cannabis research and policy in the Middle East during the 1970s, and what didn't.
There was no organized 'medical cannabis advocacy movement' in the Middle East in the 1970s the way modern readers might imagine. What existed was scientific research — most notably Raphael Mechoulam's work in Israel — and longstanding folk and traditional use of hashish in Lebanon, Egypt, and elsewhere. Policy in the region was overwhelmingly prohibitionist, shaped by the 1961 Single Convention. Claims of organized 1970s patient advocacy in Arab states are largely retrospective myth.
Context: what the 1970s actually looked like
By 1970, cannabis was illegal in nearly every Middle Eastern country, a status reinforced by the 1961 UN Single Convention on Narcotic Drugs, which classified cannabis in Schedule IV — its most restrictive category [1]. Egypt had been a vocal prohibitionist voice at international drug conferences since the 1920s, when its delegate successfully pushed for hashish to be added to the 1925 Geneva Convention's controlled substances list [2]. That prohibitionist posture carried through the 1970s.
At the same time, traditional hashish use persisted across the region — particularly in Lebanon's Bekaa Valley, which became one of the world's major hashish-producing areas during the Lebanese Civil War (1975 onward) [3]. But traditional use and cultivation are not the same thing as organized medical advocacy.
The real scientific story: Mechoulam and Hebrew University
The most consequential 1970s cannabis work in the Middle East happened in a laboratory, not a protest. Raphael Mechoulam and Yechiel Gaoni at the Weizmann Institute had isolated and characterized THC in 1964 [4]. Through the 1970s, Mechoulam — by then at Hebrew University of Jerusalem — continued structural and pharmacological work on cannabinoids, including early studies on cannabidiol (CBD) and epilepsy.
A small 1980 clinical trial led by Mechoulam and colleagues tested CBD in patients with treatment-resistant epilepsy and reported reduced seizure frequency in several participants [5] Weak / limited. The study was tiny (8 patients on CBD) and not blinded by modern standards, but it is one of the earliest controlled clinical investigations of a cannabinoid for a medical indication, and the groundwork was laid in the late 1970s. This is closer to 'research advocacy' than patient advocacy — Mechoulam repeatedly argued in published work that cannabinoids deserved serious pharmaceutical investigation.
Lebanon, the Bekaa Valley, and the conflation problem
Lebanon's Bekaa Valley produced large quantities of hashish through the 1970s, especially after the civil war began in 1975 and central state authority collapsed in the region [3]. This is sometimes retroactively framed as 'cannabis tolerance' or 'de facto legalization,' but contemporaneous reporting and later analyses describe it as a war economy, not a policy stance [3] Strong evidence. There is no documented organized medical cannabis advocacy from Lebanese growers, physicians, or patients during this period. Lebanon would not seriously revisit medical cannabis legislation until 2020, when parliament passed a law permitting cultivation for medical and industrial use [6].
Egypt and the prohibitionist legacy
Egypt's relationship with hashish in the 1970s was overwhelmingly criminal-justice oriented. Historian Liat Kozma has documented that Egyptian authorities in the early 20th century framed hashish as a public health menace, and that framing persisted [2]. There is no credible historical record of an organized Egyptian medical cannabis movement in the 1970s. Traditional and recreational use existed widely; advocacy for medical reform did not.
Where the myths come from
Modern cannabis media sometimes projects today's advocacy framework backward, implying that the 1970s Middle East had organized medical reformers. A few sources of this confusion:
- Mechoulam's research is conflated with advocacy. He was a scientist publishing pharmacology, not running a patient access campaign Strong evidence.
- Bekaa Valley cultivation is conflated with policy reform. It was a war economy Strong evidence.
- Traditional and religious use is conflated with medical advocacy. Sufi and folk traditions of hashish use are centuries old [7], but using a substance and advocating for its medical legalization are different acts Strong evidence.
The organized medical cannabis advocacy movement is largely a phenomenon that emerged in the United States in the 1990s (notably around Proposition 215 in California in 1996) and spread from there. Backdating it to 1970s Middle East is anachronistic.
What can be said with confidence
- Israel hosted world-leading cannabinoid chemistry research throughout the 1970s, led by Mechoulam Strong evidence.
- An early, small clinical trial of CBD for epilepsy was conducted in Israel and published in 1980, with groundwork in the late 1970s [5] Weak / limited.
- Lebanon was a major hashish producer, driven by civil war economics rather than medical policy Strong evidence.
- No major Middle Eastern country reformed cannabis law for medical use during the 1970s Strong evidence.
- Claims of organized 1970s Middle Eastern medical cannabis advocacy movements are not supported by primary sources Strong evidence.
Sources
- Government United Nations. Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol.
- Peer-reviewed Kozma, L. (2011). Cannabis Prohibition in Egypt, 1880–1939: From Local Ban to League of Nations Diplomacy. Middle Eastern Studies, 47(3), 443–460.
- Reported Hubbard, B. (2018). Lebanon Takes a Step Toward Legalizing Medical Marijuana. The New York Times.
- Peer-reviewed Gaoni, Y., & Mechoulam, R. (1964). Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish. Journal of the American Chemical Society, 86(8), 1646–1647.
- Peer-reviewed Cunha, J. M., Carlini, E. A., Pereira, A. E., Ramos, O. L., Pimentel, C., Gagliardi, R., Sanvito, W. L., Lander, N., & Mechoulam, R. (1980). Chronic administration of cannabidiol to healthy volunteers and epileptic patients. Pharmacology, 21(3), 175–185.
- Reported Chehayeb, K. (2020). Lebanon legalises cannabis cultivation for medical use. Al Jazeera.
- Book Rosenthal, F. (1971). The Herb: Hashish versus Medieval Muslim Society. Leiden: E.J. Brill.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.